Found: 6
Select item for more details and to access through your institution.
Prognostic Values of Inflammatory Indexes and Clinical Factors in Patients with Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma and Treated with Tyrosine Kinase Inhibitors.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 3, p. 404, doi. 10.3390/jpm12030404
- By:
- Publication type:
- Article
Evaluation of Sarcopenia, Frailty, and Inflammation on Adverse Events and Survival Outcomes in Patients with Oral Cavity Squamous Cell Carcinoma under Adjuvant Chemoradiotherapy.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 9, p. 936, doi. 10.3390/jpm11090936
- By:
- Publication type:
- Article
Systemic Inflammation Index and Tumor Glycolytic Heterogeneity Help Risk Stratify Patients with Advanced Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma Treated with Tyrosine Kinase Inhibitor Therapy.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 309, doi. 10.3390/cancers14020309
- By:
- Publication type:
- Article
Association of Neutrophil-to-Lymphocyte Ratio and Bloodstream Infections with Survival after Curative-Intent Treatment in Elderly Patients with Oral Cavity Squamous Cell Carcinoma.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 3, p. 493, doi. 10.3390/diagnostics13030493
- By:
- Publication type:
- Article
Perioperative exercise intervention in patients with lung cancer: A systematic literature review of randomized controlled trials.
- Published in:
- Tzu Chi Medical Journal, 2021, v. 33, n. 4, p. 412, doi. 10.4103/tcmj.tcmj_273_20
- By:
- Publication type:
- Article
Movement-based mind-body interventions for cardiac rehabilitation: An updated systematic review of randomized controlled trials.
- Published in:
- Tzu Chi Medical Journal, 2022, v. 34, n. 1, p. 49, doi. 10.4103/tcmj.tcmj_277_20
- By:
- Publication type:
- Article